CCH not affected by voluntary medication recall

GILLETTE, WY – Campbell County Health (CCH) has been advised of a voluntary recall of two lots of medication Veklury®, also known as Remdesivir (100mg for injection). The voluntary recall is due to the presence of glass particles.

“Upon thorough review of all shipments of Remdesivir received by Campbell County Health, we have not had or administered medication that is affected in this recall” said Kirsi Ludwig, Ph. D., Pharmacy Director.

Remdesivir is the medication used to treat COVID-19 positive patients who are hospitalized. Administration of Remdesivir is determined through many variables and not every hospitalized COVID-19 patient had or will receive this medication.

Pharmaceutical manufacturer, Gilead Sciences Inc., distributed the affected vials nationwide beginning in October 2021. Lot number 2141001-1A was distributed to wholesalers between October 25 and October 26, 2021; lot number 2141002-1A was distributed to wholesalers between October 25 and November 2, 2021.

Consumers with questions regarding this recall can contact Gilead Medical Information at 1-866-633-4474 Monday-Friday, 6 am - 4 pm PST online at www.askgileadmedical.com. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

• Complete and submit the report Online
• Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.